MK Proteins Fair Value
MK Proteins (MKPL) average fair value is ₹17.24 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹5.23 (+229.67%), fair value range ₹3.92–₹29.44. For live price and a broader fundamental view, visit MKPL stock live price.
Fair Value Analysis Export
MKPL Fair Value vs Current Price — Valuation Summary
MKPL average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Explore MKPL intrinsic value to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
MKPL Fair Value Analysis — Data Sources & Coverage
MK Proteins financial data sources, valuation methods applied and sector benchmarks used. Analyse MKPL shareholding pattern to track promoter, FII and institutional holdings.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
MKPL vs FMCG Sector Peers — P/E, P/B & Market Cap
MK Proteins P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Sarda Proteins | SRDAPRT | -223.5 | 0.85 | ₹76 |
| Swasth Foodtech | SWASTH | 4.01 | 0.43 | ₹9 |
| Shreeji Global FMCG | SHETHJI | - | 2.55 | ₹286 |
| Evexia Lifecar | EVEXIA | 59.0 | 0.21 | ₹115 |
| Nath Bio-Genes | NATHBIOGEN | 6.27 | 0.42 | ₹291 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.